Supplemental Experimental Procedures

DNA constructs and stable cell lines
The cDNAs of CreER T2 , CFP and floxed-DsRed-floxed-eGFP were cloned into a pLV.CMV construct. The cDNA of Cre was cloned into a pcDNA3.1 construct. Multiple rounds of flow cytometry were performed to obtain floxed-DsRed-floxed-eGFP-expressing cell lines that were negative for eGFP. After prolonged culturing of the cells, flow cytometry was repeated.
Tamoxifen treatment of CreER T2 cells and tumors
To activate the tamoxifen-inducible Cre variant (CreER T2 ), 5 mg tamoxifen (Sigma, St. Louis, MO, USA) was injected intraperitoneally twice a week in mice bearing tumors of ≥ 5 mm 3 ( Figure 4E (MDA-MB-231 and PyMT tumors), Figure S2 , and Figure S6 ), or for in vitro culture experiments cells were treated with 4-OH tamoxifen (3 µM; Sigma, St. Louis, MO, USA; Figure   3A -C and Figure S6A ). For the experiments involving T47D and MCF-7, tamoxifen could not be used since these lines require estrogen to grow in vivo. For experiments involving these lines, and other experiments that required a direct comparison between various lines, the "normal"
Cre variant was used that does not require tamoxifen induction for activity ( Figure 3D -E, Figure   4B -D, Figure 4E (T47D and B16 tumors), Figure 5 , Figure 6 , Figure 7 , Figure S3 , Figure S4 and Figure S5 ).
Co-cultures and transwell experiments
For all co-culture and transwell experiments, complete DMEM culture medium was used. MDA-MB-231 Cre + cells were co-cultured with MCF-7, T47D or MDA-MB-231 reporter + cells for one week prior to imaging in a culture dish. All experiments were done in parallel. For the transwell experiments, transwells with a pore-size of 400 nm (Greiner Bio-one, Frickenhause, Germany) were placed in a culture dish with reporter + cells for one week prior to imaging. The cells in the culture dish were imaged with a Leica AF7000 microscope (Mannheim, Germany) using a 10x objective. During imaging, cells were kept at 37°C in a humidified atmosphere containing 5% CO 2 . A 430/24 nm excitation filter and a 470/40 nm emission filter was used for CFP, a 470/40 nm excitation filter and a 520/40 nm emission filter was used for eGFP, and a 572/35 nm excitation filter and a 640/50 nm emission filter was used for DsRed. Every 30 minutes CFP, eGFP and DsRed images were acquired for 15 hours, and the images were analyzed in ImageJ 
Injection of tumor cells
One week before injection of Cre + and reporter + tumor cells that included T47D and/or MCF-7 tumor cells, mice were ovariectomized and implanted with an estrogen pellet (0.72 mg/pellet, 60-day release, Innovative Research of America, Sarasota, FL, USA) using a precision trochar, as per the manufacturer's instructions. For injections that did not include T47D and/or MCF-7 tumor cells, mice were not overiectomized. For tumor development, 5 x 10 5 MDA-MB-231 cells, 1 x 10 6 T47D/MCF-7 cells, 1 x 10 5 B16 cells or mixtures of 2.5 x 10 5 MDA-MB-231 cells and 5 x 10 5 T47D/MCF-7 cells were injected in the fourth and/or ninth mammary fat pad of female NSG mice (for the MDA-MB-231, T47D and MCF-7 cell lines) or B6 mice (for the B16 melanoma cell lines) of 8-20 weeks old. Prior to injection, MDA-MB-231 or B16 cells were resuspended in sterile PBS and T47D or MCF-7 cells were resuspended in sterile PBS with 50% growth factorreduced matrigel (BD Biosciences, Franklin Lakes, NJ, USA).
Transplantation of tumor pieces
MMTV-PyMT;R26-CreER T2 or MMTV-PyMT;R26-Confetti tumors were dissected aseptically from mice, cut into 2-3 mm 3 tumor pieces and stored in liquid N 2 in 80% FBS/20% DMSO until transplantation. Tumor pieces were implanted in the fourth and/or ninth mammary fat pad of NSG mice through a small skin incision. The incision was closed with a sterile 4-0 prolene suture (Ethicon, San Angelo, Texas, USA). 5 mg tamoxifen (Sigma, St. Louis, MO, USA) was injected intraperitoneally twice a week in mice bearing tumors ≥ 5 mm 3 . Mice bearing tumors of ~10 mm 3 were sacrificed and tumors were removed.
Tumor and tissue processing
Tumors and tissues were removed from the mice at the end of the experiment and fixed in periodate-lysine-paraformaldehyde (PLP) buffer (2.5 ml 4% PFA + 0.0212 g NaIO 4 + 3.75 ml L-Lysine + 3.75 ml P-buffer (pH 7.4)) O/N at 4°C. The following day, the fixed tumors and tissues were washed twice with P-buffer and placed for at least 6 hours in 30% sucrose at 4°C. The tumors and tissues were then embedded in tissue freezing medium (Leica Microsystems, Nussloch, Germany) and stored at -80°C before cryosectioning.
Immunostainings and confocal microscopy of tissue sections
Tumor or tissue cryosections (15 μm thick when used for subsequent immunostainings, 100-150 μm thick for all other experiments) were rehydrated for 10 min in Tris 0.1 M pH 7.4, when indicated used for immunostainings and embedded in Vectashield mounting medium (hard set;
Vector Labs, Burlington, Ontario, Canada). Immunostainings were performed using the following primary antibodies: rat anti-mouse CD45 biotin (eBioscience, San Diego, CA, USA; dilution 1:500), rat anti-mouse Ly-6G (Gr-1) (eBioscience, San Diego, CA, USA; dilution 1:100) and rat anti-mouse F4/80 biotin (Life Technologies, Carlsbad, CA, USA; dilution 1:400). Streptavidin-647 (Life Technologies, Carlsbad, CA, USA; dilution 1:500) and anti-rat Alexa-647 (Invitrogen Life Technologies, Paisley, UK; dilution 1:500) were used as secondary antibodies. When 6 indicated, cryosections were counterstained with 0.1 μg/ml DAPI (Invitrogen Life Technologies, Paisley, UK) to visualize the nuclei. Images were acquired using a Leica SP5 or SP8 AOBS confocal microscope (Mannheim, Germany) equipped with 10x NA 0.3 and 20x NA 0.7 dry objectives. DAPI and CFP were excited with a UV 405 nm laser, and emission was collected at 415-455 nm for DAPI and 455-495 nm for CFP. eGFP and YFP were excited with an argon ion laser (at 488 nm and 514 nm respectively) and emission was collected at 490-515 nm for eGFP and 520-560 nm for YFP. DsRed and tdTomato were excited with a 561 nm laser and emission was collected at 570-620 nm. Alexa-647 was excited with a 639 nm laser and emission was collected at 620-675 nm. At least 45 frozen sections per mouse were analyzed.
Isolation and injection of EVs
To isolate EVs from cells grown in vitro, cells were cultured in 200 ml medium supplemented with EV-free FBS (FBS centrifuged for 1 h at 70,000 g) for 48-72 h. To isolate EVs from primary PyMT tumors, tissue was dissociated using Liberase (Roche, Basel, Schweiz) without mechanical dissociation (to prevent breakage of cells): tumor pieces were incubated for 30 min at 37°C in Liberase (5 Wünsch units/ml)/DNaseI (25 μg/ml; Roche, Basel, Schweiz). Cells and cellular debris were removed from the cell culture or primary tumor supernatant by differential centrifugation: 2 x 500 g for 10 min, 2 x 2,000 g for 15 min, and 2 x 16,500 g for 20 min. EVs were pelleted by high-speed centrifugation at 70,000 g for 1 h, washed with PBS, and pelleted again by high-speed centrifugation at 70,000 g for 1 h. All high-speed centrifugation steps were performed at 4°C using a Beckman Avanti J-30I with a JS-24.38 rotor (Beckman Coulter, Fullerton, CA, USA). Finally, EVs were resuspended in 200 μl PBS, analyzed by electron microscopy and NanoSight to determine purity and size distribution of the EVs and/or used for injection experiments. Before the injection of EVs in reporter + tumors in mice, EVs were treated with 20 µg/ml proteaseK (protK; Promega, Madison, WI, USA) followed by heat inactivation at 60°C for 10 min and 10 µg/ml RNaseA (Roche, Basel, Schweiz) followed by heat inactivation at using the Avian Myeloblastosis Virus Reverse Transcriptase kit (Promega, Madison, WI, USA) according to the manufacturer's instructions. cDNA was amplified using a PCR with Cre-specific primers (forward primer: 5' GCCTGCATTACCGGTCGATGC 3'; reverse primer: 5' GTGGCAGATGGC GCGGCAACA 3'). Thermal cycle conditions used for all reactions were as follows: 5 min at 95°C, followed by 40 cycles consisting of denaturation for 30 sec at 95°C, annealing for 30 sec at 58°C, and extension for 1 min at 72°C. PCR reactions were concluded with incubation for 10 min at 72°C to complete the extension of all synthesized products. PCR products were then visualized on a 1.25% TAE agarose gel.
Electron microscopy and NanoSight particle analysis
EV size distributions were analyzed using a NanoSight LM10 system (NanoSight, Amesbury, UK). The system calculates size by tracking the Brownian motion of individual nanoparticles detected by scattered laser light as a function of dispersing medium viscosity and temperature.
Samples were diluted until individual nanoparticles could be tracked. Samples were measured five times and analyzed using Nanoparticle Tracking Analysis software (NanoSight).
For electron microscopy, EVs were fixed with 2% paraformaldehyde/0.2% glutaraldehyde solution, coated on a copper grid and post-stained with uranyl oxale acetate and methylcellulose uranyl acetate. Samples were viewed on a FEI Tecnai T12 transmission electron microscope (FEI, Hillsboro, Oregon, USA), and images were digitally taken using a CCD camera and FEI version 3.2 TEM Imaging and Analysis Software.
